CN110604225A - Pig intestinal health regulator and preparation method thereof - Google Patents
Pig intestinal health regulator and preparation method thereof Download PDFInfo
- Publication number
- CN110604225A CN110604225A CN201810619106.8A CN201810619106A CN110604225A CN 110604225 A CN110604225 A CN 110604225A CN 201810619106 A CN201810619106 A CN 201810619106A CN 110604225 A CN110604225 A CN 110604225A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- intestinal health
- extract
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007413 intestinal health Effects 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000000419 plant extract Substances 0.000 claims abstract description 30
- 239000002535 acidifier Substances 0.000 claims abstract description 28
- 241000411851 herbal medicine Species 0.000 claims abstract description 17
- 239000006041 probiotic Substances 0.000 claims abstract description 16
- 235000018291 probiotics Nutrition 0.000 claims abstract description 16
- 239000002131 composite material Substances 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940075887 saccharomyces cerevisiae extract Drugs 0.000 claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 6
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 claims description 11
- 241000282887 Suidae Species 0.000 claims description 11
- 229940084560 sanguinarine Drugs 0.000 claims description 11
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 claims description 11
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000003674 animal food additive Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 8
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 8
- 240000007849 Macleaya cordata Species 0.000 claims description 8
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 8
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 8
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 8
- 229940074393 chlorogenic acid Drugs 0.000 claims description 8
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 8
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 8
- -1 compound vitamin Chemical class 0.000 claims description 8
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017454 sodium diacetate Nutrition 0.000 claims description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 241000357625 Campanumoea Species 0.000 claims description 5
- 241000193171 Clostridium butyricum Species 0.000 claims description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 5
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 claims description 5
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims description 5
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims description 5
- 235000007746 carvacrol Nutrition 0.000 claims description 5
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims description 5
- 229940117916 cinnamic aldehyde Drugs 0.000 claims description 5
- 239000011162 core material Substances 0.000 claims description 5
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 claims description 5
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims description 5
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 239000011652 vitamin K3 Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 4
- 239000005770 Eugenol Substances 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 4
- 239000012164 animal wax Substances 0.000 claims description 4
- 229960002217 eugenol Drugs 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 239000012178 vegetable wax Substances 0.000 claims description 4
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 3
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000011087 fumaric acid Nutrition 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 22
- 239000003242 anti bacterial agent Substances 0.000 abstract description 17
- 229940088710 antibiotic agent Drugs 0.000 abstract description 14
- 230000000694 effects Effects 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 21
- 230000000844 anti-bacterial effect Effects 0.000 description 13
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 102000007641 Trefoil Factors Human genes 0.000 description 5
- 108010007389 Trefoil Factors Proteins 0.000 description 5
- 235000014590 basal diet Nutrition 0.000 description 5
- 235000021050 feed intake Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 4
- 229940124350 antibacterial drug Drugs 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000019629 palatability Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- TURHTASYUMWZCC-UHFFFAOYSA-N Olaquindox [BAN:INN] Chemical compound C1=CC=C2N([O-])C(C)=C(C(=O)NCCO)[N+](=O)C2=C1 TURHTASYUMWZCC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006030 antibiotic growth promoter Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 244000237330 gutta percha tree Species 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229950010210 olaquindox Drugs 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 229930015704 phenylpropanoid Natural products 0.000 description 2
- 125000001474 phenylpropanoid group Chemical group 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000004053 quinones Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- IOKWXGMNRWVQHX-VAWYXSNFSA-N (e)-1-(3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)-3-phenylprop-2-en-1-one Chemical compound O=[N+]1C2=CC=CC=C2N([O-])C(C)=C1C(=O)\C=C\C1=CC=CC=C1 IOKWXGMNRWVQHX-VAWYXSNFSA-N 0.000 description 1
- CUJMCPPBTUATEJ-UHFFFAOYSA-N 1-(3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)ethanone Chemical compound C1=CC=C2[N+](=O)C(C(=O)C)=C(C)N([O-])C2=C1 CUJMCPPBTUATEJ-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000004181 Flavomycin Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 101100481014 Sus scrofa TFF3 gene Proteins 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000002942 anti-growth Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019374 flavomycin Nutrition 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000001937 non-anti-biotic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 239000002719 pyrimidine nucleotide Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
The invention belongs to the technical field of pig feed, and particularly relates to a pig intestinal health regulator and a preparation method thereof, wherein the regulator comprises the following components in parts by weight: 50-80 parts of acidifier, 20-50 parts of plant extract, 1-3 parts of probiotics, 1-5 parts of saccharomyces cerevisiae extract, 1-3 parts of composite Chinese herbal medicine, 0.5-1.5 parts of glutamine and 15-35 parts of coated composite vitamin. The regulator prepared by the invention can replace antibiotics to be used in pig feed, prevent pig diarrhea and promote pig growth.
Description
Technical Field
The invention belongs to the technical field of pig feed, and particularly relates to a pig intestinal health regulator and a preparation method thereof.
Background
Feed antibiotics include antibiotic growth promoters and therapeutic antibiotics. The former is an antibiotic which is widely used in the feeding of edible animals and can improve the production benefit of the animals; the latter is mainly used for therapy, i.e. the feed used by the animal in the diseased state, to which some antibiotics can be added in the case of veterinary prescriptions.
Antibiotics were added as growth promoters to feed, beginning in the 50's of the 20 th century, with the aim of promoting growth, improving feed utilization, reducing mortality and improving reproductive performance. In 1950, antibiotics are allowed to be added into feed, and are beginning to be widely used as growth promoters in livestock and poultry breeding.
For a long time, the antibiotic growth promoter has good effect when applied to the animal husbandry production, is regarded as the largest biotechnology of the 21 st century livestock breeding, and greatly promotes the development of the livestock breeding industry and the feed industry. Approximately 50% of the total antibiotic production worldwide was used in animal husbandry in 1996, but due to the continuous low-level feeding of antibiotics, the hazards of bacterial drug resistance, drug residues in animal products, anaphylactic toxic reactions, and "triple effects" (mutagenicity, carcinogenesis and teratogenesis) are becoming more and more significant. The occurrence of human drug resistance events directly threatens human health and safety, causes consumer panic, and forces livestock and poultry breeding to change production modes.
In 22.6.2017, the ministry of agriculture formally establishes a national plan for suppressing animal-derived bacteria drug resistance activities (2020 2017), wherein 6 important tasks are specified, the first task is the exit of growth-promoting antibacterial drugs, which is divided into three categories: the first type is a common antibacterial drug for promoting growth of human and animals, such as a chlortetracycline premix, which is required to be cleaned; the second type is a special antibacterial drug for growth-promoting animals, such as a flavomycin premix, and policy suggestions for reservation or withdrawal need to be formed; the third type is quinoxaline antibacterial drugs, such as mequindox, olaquindox, quinocetone and the like, and a gradual exit scheme is formed.
Nowadays, olaquindox, organic arsenic and other drug feed additives are forbidden, and in the future, more and more 168 bulletins will be provided to stipulate that the currently temporarily allowed "drug-added" products will be forbidden, so that the health and immunity of animals need to be improved from the aspects of feeding management, nutrition level, environmental control and the like, and the use of growth-promoting drug feed additives is gradually reduced.
The main effects of antibiotics on animal body are bacteriostasis and growth promotion. At present, a plurality of products with antibacterial and growth promoting effects are available at home and abroad, and comprise microecologics, antibacterial peptides, organic acids, polysaccharide/oligosaccharide, plant extracts, plant essential oil, Chinese herbal medicines, novel enzyme preparations and the like. Although there are many products available for user selection, there are few and few that can truly provide customers with a comprehensive antibiotic alternative.
The feeding acidifier is a novel additive capable of reducing the pH value of the feed in the digestive tract and providing the most suitable digestive tract environment for animals, and has a single type and a compound type. The acid component includes inorganic acid and organic acid. But the antibacterial agent has a better effect only on piglets in the nursery stage, and has the problems of large addition amount, corrosion on production equipment and the like although the antibacterial effect is obvious. The enzyme is a catalyst for various chemical reactions in the metabolism process in the organism, and has specificity and high efficiency. The enzyme preparation added into the feed is a product with biological activity produced by fermentation of various microorganisms. The enzyme preparation mainly comprises digestive enzymes such as protease, amylase and cellulose powder enzyme; and enzymes for improving feed quality, such as xylanase, pentosanase, pectinase and phytase. The enzyme preparation can improve the feed conversion rate, but has poor bacteriostatic effect. The plant extract is a research hotspot in recent years, and the types of the components of the plant extract are very many, and mainly comprise various types such as flavonoids, alkaloids, glycosides, quinones, phenylpropanoids, tannins, lipids, volatile oils and the like. The effects in animal bodies are mainly antibacterial, bactericidal, antioxidant and the like. But simultaneously, a plurality of plant extracts have the defects of easy volatilization, easy oxidation, undefined active ingredients and difficult processing and production.
From the results of current experimental studies, it is difficult to completely replace antibiotics with a single product to achieve the anti-diarrhea and growth-promoting effects, and the problem must be solved through comprehensive scheme proportioning.
Disclosure of Invention
The invention mainly provides a pig intestinal health regulator and a preparation method thereof, and the regulator can be used in pig feed instead of antibiotics to prevent pig diarrhea and promote pig growth. The technical scheme is as follows:
an intestinal health regulator for pigs comprises the following components in parts by weight: 50-80 parts of acidifier, 20-50 parts of plant extract, 1-3 parts of probiotics, 1-5 parts of saccharomyces cerevisiae extract, 1-3 parts of composite Chinese herbal medicine, 0.5-1.5 parts of glutamine and 15-35 parts of coated composite vitamin.
Preferably, the acidifying agent is selected from one or more of formic acid, acetic acid, butyric acid, citric acid, fumaric acid, sodium diacetate and potassium sorbate, and is mixed with a silicon dioxide carrier.
Preferably, the plant extract is one or more of sanguinarine extracted from macleaya cordata, chlorogenic acid extracted from green coffee, liquiritigenin, ginkgetin, cinnamaldehyde, carvacrol and eugenol.
Preferably, the probiotics are at least two of clostridium butyricum, lactobacillus and bacillus subtilis.
Preferably, the compound Chinese herbal medicine is a mixture of campanumoea root, hawthorn, Chinese date and dried orange peel.
Preferably, the core material coated with the compound vitamin comprises vitamin A and vitamin D3Vitamin E, vitamin K3Vitamin B1Vitamin B2Vitamin B6Vitamin B12The wall material coated with the compound vitamin comprises one or more of vegetable wax, animal wax and gelatin.
A preparation method of the pig intestinal health regulator comprises the following steps: mixing 70-80% of the formula amount of coated multivitamin with the formula amount of acidifier, probiotics, plant extract, Saccharomyces cerevisiae extract, compound Chinese herbal medicine and glutamine, mixing well, adding the rest coated multivitamin, and mixing well to obtain the compound feed additive.
By adopting the scheme, the invention has the following advantages:
the product is designed aiming at the characteristics of the gastrointestinal tract of pigs, particularly weaned piglets, and consists of an acidifier and a plant extract, wherein the acidifier has the effects of improving the palatability of piglet feed, enhancing the digestion function of the weaned piglets, preventing and controlling animal diarrhea and promoting the production performance of the piglets. The plant extract has antibacterial effect and can increase feed intake.
Detailed Description
In recent years, a great deal of research proves that acidifiers and plant extract products have diarrhea-resisting and growth-promoting effects similar to antibiotics and can replace antibiotics. The acidifier and plant extract compound product can be used as a novel green feed additive, is expected to become an antibiotic substitute for feed enterprises in the course of non-antibiotic feed reformation, and has good market space and prospect.
(1) According to the action mechanism and the effect of the acidifier, the stomach digestive acid and the intestinal acid are reasonably selected to achieve the effects of improving the palatability of the piglet feed, enhancing the digestive function of the weaned piglets, preventing and controlling animal diarrhea and promoting the production performance of the piglets.
(2) At present, the plant extract feed additive is mostly added in a mode of adding crushed materials into feed, and the processing technology comprises coarse powder, fine powder, superfine powder, low-temperature condensation superfine powder and the like. The addition technology is laggard behind, the dosage is large, the palatability is poor, the loss of active ingredients is large, the ingredients are complex, the action effect is unstable, the effective ingredients in the plant extract are not uniform, the balanced pharmacological action is difficult to play, the blindness is large, the product quality standard is difficult to formulate, the large-scale production, the popularization and the application are not facilitated, and the resource waste is serious. According to the method, the optimal production process is optimized by researching the active ingredients of the plant extracts, researching the aggregation parts of the plant active ingredients, adopting the processes of distillation extraction and the like and using single or combined process treatment, so that the content of the active ingredients is concentrated, the active substances are more stable, and substances for improving palatability are added to enhance the feed intake of piglets. The in-vitro antibacterial effect of the active ingredients of the plant extract is researched, the antibacterial spectrum and the antibacterial effect of the acidifier product are synthesized according to the antibacterial spectrum and the antibacterial ability, and the proportion of the plant extract is optimized.
The acidifier is an antibacterial rehabilitation feed additive accepted in the industry at present, short-chain fatty acids such as formic acid and acetic acid have good acidification effect, and meanwhile, the acidifier has good inhibition and killing effects on escherichia coli, salmonella and clostridium perfringens, and citric acid, fumaric acid, butyric acid and the like have good promotion effect on beneficial bacteria at the tail end of intestinal tracts. Many components of the acidifier can be directly absorbed and utilized by animals as nutritional ingredients of the animals. The acidifier has a very clear bacteriostatic mechanism, is not easy to generate tolerance for bacteria, and can be stably used for a long time.
The sodium diacetate has better acidification and corrosion prevention effects than sodium sorbate and has price advantage, so the sodium diacetate is selected as the first choice of the acidulant. Chlorogenic acid is a popular substitute for antibiotics in recent years, but chlorogenic acid from lonicera confusa and eucommia ulmoides is high in price, and chlorogenic acid content of the green coffee is high and low in price, so that the chlorogenic acid can be used as a substitute of an eucommia ulmoides extract. The macleaya cordata is also high in price, the price of 5% sanguinarine content reaches 650 yuan/kg, the macleaya cordata with the concentration of 1% is selected, the price is 70 yuan/kg, and the addition amount reaches 10%, so that the sanguinarine concentration can reach the level of 0.1%. The content of the contained active sanguinarine in the raw materials for treating the melania is about 0.137%, and the addition amount of the active sanguinarine is about 400g, so that the effect of replacing antibiotics can be achieved.
The main components of plant extracts are various, such as flavonoids, alkaloids, glycosides, quinones, phenylpropanoids, tannins, lipids, volatile oils, etc. The flavonoid products comprise ginkgetin, liquiritigenin and the like, while alkaloids such as sanguinarine extracted from macleaya cordata and the Meiyouzhu which takes the sanguinarine as a main active ingredient are the new stars of anti-diarrhea growth-promoting products in the industry at present. The volatile oil substances including cinnamaldehyde, carvacrol, eugenol and the like are used as main raw materials of essential oil products, have good antibacterial effect and fragrant smell, and can remarkably promote the increase of the feed intake of animals.
The potassium sorbate is a common intestinal acidifier, has the effects of sterilization and bacteriostasis, and can be used as one of the raw materials with lower cost. However, the amount should not be too high, since it tends to form lumps.
The small intestine is the main part of glutathione metabolism, Gln can synthesize purine nucleotide, pyrimidine nucleotide and important antioxidant glutathione, and is also the precondition of proline and arginine synthesis and the important component of body protein. Glutamine not only provides energy for the metabolism of intestinal mucosa epithelial cells, but also provides substrates for gluconeogenesis and urea synthesis of the liver. Research on intestinal nutrition of human and monogastric animals shows that Gln is an important energy source substance of intestinal mucosal cells and can promote growth, repair and integrity maintenance of mucosa. The use of a small amount of glutamine can help the recovery of intestinal mucosa of weaned pigs.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The experimental methods in the following examples are conventional methods unless otherwise specified, and the experimental reagents and materials involved are conventional biochemical reagents and materials unless otherwise specified.
Example 1
1. An intestinal health regulator for pigs comprises the following components in parts by weight: 60 parts of acidifier, 50 parts of plant extract, 3 parts of probiotics, 3 parts of saccharomyces cerevisiae extract, 2 parts of composite Chinese herbal medicine, 1 part of glutamine and 20 parts of coating composite vitamin.
Wherein the acidifying agent is a mixture of 10 parts of formic acid, 10 parts of citric acid, 10 parts of fumaric acid and 30 parts of a silica carrier.
The plant extract is a mixture of 10 parts of macleaya cordata extract sanguinarine, 10 parts of green coffee extract chlorogenic acid, 10 parts of liquiritigenin, 10 parts of cinnamaldehyde and 10 parts of eugenol.
The probiotics are a mixture of 5 hundred million U/g clostridium butyricum and 100 hundred million U/g lactobacillus.
The compound Chinese herbal medicine is a mixture of 1 part of campanumoea root and 1 part of hawthorn.
The core material coated with the compound vitamin comprises vitamin A and vitamin D3Vitamin E, vitamin K3Vitamin B1Vitamin B2Vitamin B6Vitamin B12Niacin, pantothenic acid, folic acid and biotin, wherein the wall material coated with the multivitamins comprises vegetable wax.
2. The preparation method of the intestinal health regulator for the pigs comprises the following steps: mixing 70% of the coated multivitamin, acidifying agent, probiotics, plant extract, saccharomyces cerevisiae extract, composite Chinese herbal medicine and glutamine, uniformly mixing, adding the rest coated multivitamin, and fully mixing to obtain the composite feed additive.
Example 2
1. An intestinal health regulator for pigs comprises the following components in parts by weight: 80 parts of acidifier, 40 parts of plant extract, 2 parts of probiotics, 5 parts of saccharomyces cerevisiae extract, 1 part of composite Chinese herbal medicine, 0.5 part of glutamine and 15 parts of coating composite vitamin.
Wherein the acidifying agent is a mixture of 10 parts of acetic acid, 10 parts of butyric acid, 20 parts of citric acid, 5 parts of sodium diacetate, 5 parts of potassium sorbate and 30 parts of silica carrier.
The plant extract is a mixture of 10 parts of macleaya cordata extract sanguinarine, 10 parts of ginkgetin and 20 parts of carvacrol.
The probiotics is a mixture of clostridium butyricum, lactobacillus and bacillus subtilis.
The compound Chinese herbal medicine is prepared by mixing 0.3 part of campanumoea root, 0.3 part of hawthorn and 0.4 part of dried orange peel.
The core material coated with the compound vitamin comprises vitamin A and vitamin D3Vitamin E, vitamin K3Vitamin B1Vitamin B2Vitamin B6Vitamin B12Nicotinic acid, pantothenic acid, folic acid and biotin, wherein the wall material for coating the multivitamins comprises vegetable waxOne or more of animal wax and gelatin.
2. The preparation method of the intestinal health regulator for the pigs comprises the following steps: mixing 80% of the coated multivitamin, acidifying agent, probiotics, plant extract, Saccharomyces cerevisiae extract, compound Chinese herbal medicine and glutamine, mixing uniformly, adding the rest coated multivitamin, and mixing fully to obtain the compound feed additive.
Example 3
1. An intestinal health regulator for pigs comprises the following components in parts by weight: 50 parts of acidifier, 20 parts of plant extract, 1 part of probiotics, 1 part of saccharomyces cerevisiae extract, 3 parts of composite Chinese herbal medicine, 1.5 parts of glutamine and 15 parts of coating composite vitamin.
Wherein the acidifying agent is a mixture of 10 parts of butyric acid, 10 parts of sodium diacetate, 10 parts of potassium sorbate and 20 parts of silica carrier.
The plant extract is mixture of sanguinarine extracted from Macleaya cordata, chlorogenic acid extracted from green coffee, liquiritigenin, ginkgetin, cinnamaldehyde and carvacrol.
The probiotics is a mixture of clostridium butyricum, lactobacillus and bacillus subtilis.
The compound Chinese herbal medicine is a mixture of 1 part of campanumoea root, 0.5 part of hawthorn, 1 part of Chinese date and 0.5 part of dried orange peel.
The core material coated with the compound vitamin comprises vitamin A and vitamin D3Vitamin E, vitamin K3Vitamin B1Vitamin B2Vitamin B6Vitamin B12The wall material coated with the compound vitamin comprises one or more of vegetable wax, animal wax and gelatin.
2. The preparation method of the intestinal health regulator for the pigs comprises the following steps: mixing 75% of the coated multivitamin, acidifying agent, probiotics, plant extract, Saccharomyces cerevisiae extract, compound Chinese herbal medicine and glutamine, mixing uniformly, adding the rest coated multivitamin, and mixing fully to obtain the compound feed additive.
Study of the effects
1 materials and methods
1.1 test time and location
Test time: acclimatization is carried out for 1 week in 24 months in 2017 and 11 months in 2017, and formal test is carried out for 6 weeks; test site: jiangpu test pig farm of Nanjing university of agriculture.
1.2 test animals
90 healthy ordinary grade 'Du X big X long' ternary hybrid weaned piglets are purchased from Jiangpu experimental pig farm of Nanjing agriculture university. After adapting to the environment, the samples were randomly divided into 5 groups of 18 samples. The basal diet (blank control group), basal diet +1g/kg intestinal health regulator (0.1% group), basal diet +3g/kg intestinal health regulator (0.3% group), basal diet +5g/kg intestinal health regulator (0.5% group) and basal diet +3g/kg bacillus microecologics (microecologics group) were fed, respectively. The test period was 42 days.
1.3 test daily ration and additives
The test ration was a basal ration, as shown in table 1, to which 0.1% intestinal health regulator, 0.3% intestinal health regulator, 0.5% intestinal health regulator, and 0.3% bacillus microecological preparation were added, respectively. The intestinal health regulator is provided by Ohmei Biotechnology Inc. of Jiangsu, and the microecological preparation mainly comprises Bacillus and is commercially available.
TABLE 1 basal ration proportion and nutritional level for experimental piglets
1.4 growth Performance test
At 1d and last 1d morning 8: 00 empty stomach, and calculating average daily gain according to initial weight and final weight. Average daily gain-average net head gain/day of experiment. And recording the feed intake of the piglets, calculating the daily average feed intake, and calculating the feed-weight ratio after the experiment is finished. The feces of the piglets were observed regularly every day, the number of diarrhea heads was recorded, and the diarrhea rate (%) was calculated as the number of total diarrhea/(total number of heads × number of test days) × 100. The diarrhea index is the sum of stool scores/total number of test pigs (see table 2 for scoring criteria), and a higher index indicates more severe diarrhea.
TABLE 2 diarrhea score criteria
Table1 The standard scores of diarrhea in weaned piglets
1.5 mechanism test for anti-diarrhea
5mL of blood is collected from the early morning fasting vena cava of the piglet in the last 1d of the experiment, and the piglet is centrifuged at 3000 r/min for 10min to obtain serum. The contents of midgut trefoil factor (TFF3), Nitric Oxide (NO) and superoxide dismutase (SOD) in serum are detected by adopting an ELISA method according to the requirements of a kit specification.
Pig TFF3, NO and SOD detection kit, purchased from Assay Biotechnology Co., Ltd, USA. The main instruments include an enzyme-labeled detector (ELx800, BioTek), a centrifuge (5810R, Eppendorf), and the like.
1.8 statistical analysis of data
The results of all detection indexes are expressed in a form of Mean plus or minus standard deviation (Mean plus or minus SD), and ANOVA (one way analysis of variance) method in statistical software SPSS 17.0 is applied to carry out variance analysis, so that the significance of difference between each dosage group and microecological group of the intestinal health regulator and a blank control group is compared.
2 results and analysis
2.1 Effect of intestinal health regulators on weaned pig Productivity
The effect of the intestinal health modulator on the productivity of weaned piglets is shown in table 3. Wherein the daily gains of the 0.5 percent group and the 0.3 percent group of the intestinal health regulator are respectively extremely obvious (P <0.01) and obvious (P <0.05) higher than that of the blank control group, and the daily food intake of the 0.5 percent group and the 0.3 percent group of the intestinal health regulator are both extremely obvious (P <0.01) higher than that of the blank control group. The diarrhea rate and the diarrhea index of the intestinal health regulator of 0.5 percent and 0.3 percent are both very obvious (P <0.01) and are lower than those of a blank control group.
TABLE 3 Effect of intestinal health Modulator on weaned piglet Productivity
Table2 The growth performance of weaned piglets in every group
Note: p <0.05, P <0.01 compared to the blank control group. Note:p <0.05,. P <0.01, vs.
2.2 changes in the Effect factors for diarrhea
The content of the diarrhea influencing factors in each group is shown in Table 4. The content of TFF3 in the 0.5% intestinal health regulator group is 19.03 +/-2.07 ng/mL, compared with a blank control group, the difference is very obvious (P is less than 0.01), and the content of TFF3 in the 0.3% intestinal health regulator group is obviously higher (P is less than 0.05) than that in the blank control group. The content of NO in the 0.5% group of the intestinal health regulator is 36.91 +/-3.61 mu mol/L, compared with the blank control group, the difference is very obvious (P is less than 0.01), and the content of NO in the 0.3% group of the intestinal health regulator is obviously lower (P is less than 0.05) than that in the blank control group. The content of SOD in the 0.5% intestinal health regulator group is 11.35 +/-1.44 ng/mL, and compared with a blank control group, the difference is obvious (P is less than 0.05).
TABLE 4 diarrhea-affecting factor content in the animals of each group
Table3 The contents of diarrhea factor in every group
3 conclusion
3.1 the intestinal health regulator can effectively increase the daily gain of piglets, and compared with a blank control group, the 0.5 percent group and the 0.3 percent group have obvious difference and present a dose-effect relationship. The food intake of the intestinal health regulator in the 0.3% group was increased by 124.99 g/day compared with the control group, and the food intake in the 0.5% group was increased by 152.38 g/day.
3.20.5% of the group had a 67.11% reduction in the diarrhea rate of the intestinal health regulator compared to the control group, whereas the diarrhea rate in the 0.3% group was 55.35% reduction compared to the control group. The diarrhea rate and the diarrhea index of the intestinal health regulator of 0.5 percent and 0.3 percent are both very obvious (P <0.01) and are lower than those of a blank control group.
3.3 intestinal health regulator can induce the superoxide dismutase of free radical to express in large quantity, and at the same time, it can up-regulate small intestine trefoil factor to repair the intestinal mucosa damaged by nitric oxide, so as to reduce edema reaction and diarrhea syndrome of organism.
Various other modifications and changes may be made by those skilled in the art based on the above-described technical solutions and concepts, and all such modifications and changes should fall within the scope of the claims of the present invention.
Claims (7)
1. An intestinal health regulator for pigs comprises the following components in parts by weight: 50-80 parts of acidifier, 20-50 parts of plant extract, 1-3 parts of probiotics, 1-5 parts of saccharomyces cerevisiae extract, 1-3 parts of composite Chinese herbal medicine, 0.5-1.5 parts of glutamine and 15-35 parts of coated composite vitamin.
2. The porcine intestinal health modulator according to claim 1, wherein: the acidifying agent is selected from one or more of formic acid, acetic acid, butyric acid, citric acid, fumaric acid, sodium diacetate and potassium sorbate, and is mixed with a silicon dioxide carrier.
3. The porcine intestinal health modulator according to claim 1, wherein: the plant extract is one or more of macleaya cordata extract sanguinarine, green coffee extract chlorogenic acid, liquiritigenin, ginkgetin, cinnamaldehyde, carvacrol and eugenol.
4. The porcine intestinal health modulator according to claim 1, wherein: the probiotics are at least two of clostridium butyricum, lactobacillus and bacillus subtilis.
5. The porcine intestinal health modulator according to claim 1, wherein: the compound Chinese herbal medicine is a mixture of campanumoea root, hawthorn, Chinese date and dried orange peel.
6. The porcine intestinal health modulator according to claim 1, wherein: the core material coated with the compound vitamin comprises vitamin A and vitamin D3Vitamin E, vitamin K3Vitamin B1Vitamin B2Vitamin B6Vitamin B12The wall material coated with the compound vitamin comprises one or more of vegetable wax, animal wax and gelatin.
7. A method for preparing the pig intestinal health regulator of claim 1, wherein the method comprises the steps of: the method comprises the following steps: mixing 70-80% of the formula amount of coated multivitamin with the formula amount of acidifier, probiotics, plant extract, Saccharomyces cerevisiae extract, compound Chinese herbal medicine and glutamine, mixing well, adding the rest coated multivitamin, and mixing well to obtain the compound feed additive.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810619106.8A CN110604225A (en) | 2018-06-15 | 2018-06-15 | Pig intestinal health regulator and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810619106.8A CN110604225A (en) | 2018-06-15 | 2018-06-15 | Pig intestinal health regulator and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110604225A true CN110604225A (en) | 2019-12-24 |
Family
ID=68888059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810619106.8A Pending CN110604225A (en) | 2018-06-15 | 2018-06-15 | Pig intestinal health regulator and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110604225A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111588707A (en) * | 2020-05-11 | 2020-08-28 | 四川英格瑞生物科技有限公司 | Livestock intestinal health product and product series |
CN113439800A (en) * | 2021-05-26 | 2021-09-28 | 河南广安生物科技股份有限公司 | Liquid acidifier for promoting ingestion of pigs and poultry and preparation method and application thereof |
CN114916616A (en) * | 2022-02-10 | 2022-08-19 | 无锡正大生物股份有限公司 | Water-soluble compound acidifier and production method thereof |
CN116211980A (en) * | 2022-12-12 | 2023-06-06 | 河南新经典生物科技有限公司 | Preparation for fattening and promoting growth of pigs and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829094A (en) * | 2014-03-11 | 2014-06-04 | 山东省农业科学院畜牧兽医研究所 | Feed additive for improving intestinal development of piglets and using method thereof |
CN104839514A (en) * | 2015-06-16 | 2015-08-19 | 漳州傲农牧业科技有限公司 | Feed additive capable of improving irritability resistance of weaning piglets, as well as preparation and application of feed additive |
CN107156483A (en) * | 2017-05-26 | 2017-09-15 | 深圳市金新农科技股份有限公司 | It is a kind of to be used to improve the fodder compound, compound premix and functional feed of Intestinal Microflora of Weanling Piglets structure |
CN108077629A (en) * | 2017-09-21 | 2018-05-29 | 湖南九鼎动物营养研究院有限公司 | A kind of nourishing the stomach shield rice noodle roll grain mixed type feed for weaned and preparation method thereof |
-
2018
- 2018-06-15 CN CN201810619106.8A patent/CN110604225A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103829094A (en) * | 2014-03-11 | 2014-06-04 | 山东省农业科学院畜牧兽医研究所 | Feed additive for improving intestinal development of piglets and using method thereof |
CN104839514A (en) * | 2015-06-16 | 2015-08-19 | 漳州傲农牧业科技有限公司 | Feed additive capable of improving irritability resistance of weaning piglets, as well as preparation and application of feed additive |
CN107156483A (en) * | 2017-05-26 | 2017-09-15 | 深圳市金新农科技股份有限公司 | It is a kind of to be used to improve the fodder compound, compound premix and functional feed of Intestinal Microflora of Weanling Piglets structure |
CN108077629A (en) * | 2017-09-21 | 2018-05-29 | 湖南九鼎动物营养研究院有限公司 | A kind of nourishing the stomach shield rice noodle roll grain mixed type feed for weaned and preparation method thereof |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111588707A (en) * | 2020-05-11 | 2020-08-28 | 四川英格瑞生物科技有限公司 | Livestock intestinal health product and product series |
CN113439800A (en) * | 2021-05-26 | 2021-09-28 | 河南广安生物科技股份有限公司 | Liquid acidifier for promoting ingestion of pigs and poultry and preparation method and application thereof |
CN114916616A (en) * | 2022-02-10 | 2022-08-19 | 无锡正大生物股份有限公司 | Water-soluble compound acidifier and production method thereof |
CN116211980A (en) * | 2022-12-12 | 2023-06-06 | 河南新经典生物科技有限公司 | Preparation for fattening and promoting growth of pigs and preparation method thereof |
CN116211980B (en) * | 2022-12-12 | 2024-03-15 | 河南新经典生物科技有限公司 | Preparation for fattening and promoting growth of pigs and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | Effects of enzyme inclusion in a maize–soybean diet on broiler performance | |
CN110604225A (en) | Pig intestinal health regulator and preparation method thereof | |
Castillejos et al. | Effects of dose and adaptation time of a specific blend of essential oil compounds on rumen fermentation | |
Baruah et al. | Interactions of dietary microbial phytase, citric acid and crude protein level on mineral utilization by rohu, Labeo rohita (Hamilton), juveniles | |
Tsai et al. | The effect of adding xylanase or β-glucanase to diets with corn distillers dried grains with solubles (CDDGS) on growth performance and nutrient digestibility in nursery pigs | |
Latorre et al. | Effects of the inclusion of a Bacillus direct-fed microbial on performance parameters, bone quality, recovered gut microflora, and intestinal morphology in broilers consuming a grower diet containing corn distillers dried grains with solubles | |
Li et al. | Effect of microbial phytase, vitamin D3, and citric acid on growth performance and phosphorus, nitrogen and calcium digestibility in growing swine | |
CA2620832C (en) | Use of dextrin in animal feeds | |
CN104012796A (en) | Biological non-antibiotic complete feed for piglet and preparation method thereof | |
CN105248897A (en) | Pig forage improving meat quality | |
CN105053724A (en) | Fodder for growing and fattening pigs | |
Kim et al. | Effects of mannan level and β-mannanase supplementation on growth performance, apparent total tract digestibility and blood metabolites of growing pigs | |
CN103005160A (en) | Compound acidifier for feed, and preparation method and application of acidifier | |
Piao et al. | Effects of Kemzyme, phytase and yeast supplementation on the growth performance and pollution reduction of broiler chicks | |
CN100333658C (en) | Tortoise and turtle feedstuff and preparing method | |
CN110353114A (en) | A kind of cow feed additive and its preparation process | |
Cristobal et al. | A new source of high-protein distillers dried grains with solubles (DDGS) has greater digestibility of amino acids and energy, but less digestibility of phosphorus, than de-oiled DDGS when fed to growing pigs | |
Lee et al. | Effects of β-mannanase supplementation on growth performance, nutrient digestibility, and nitrogen utilization of Korean native goat (Capra hircus coreanae) | |
CN107183372B (en) | Milk replacer for weaning meat calves | |
CN104621381A (en) | Compound feed with fermented cordyceps sinensis extract for weaned piglets | |
Valencia et al. | Phytase and acetic acid supplementation in the diet of early weaned piglets: effect on performance and apparent nutrient digestibility | |
CN110892944A (en) | Weaned pig feed additive capable of replacing antibiotics and application thereof | |
CN111166810A (en) | Ointment for preventing cat urinary system diseases and preparation method thereof | |
CN108142688B (en) | Zinc oxide-free conservation material | |
Mok et al. | Combination of phytase and β-mannanase supplementation on energy and nutrient digestibility in pig diets containing palm kernel expellers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191224 |
|
RJ01 | Rejection of invention patent application after publication |